162 results
Page 3 of 9
8-K
EX-1.1
kz62 nlfrb
14 Oct 20
Entry into a Material Definitive Agreement
6:04am
424B5
k3wjjh50apnj2i9nk22
13 Oct 20
Prospectus supplement for primary offering
5:27pm
S-3ASR
EX-1.2
hr8vdfql3du6dlp
8 Jul 20
Automatic shelf registration
8:50am
S-3ASR
EX-4.2
c2ujd8o
8 Jul 20
Automatic shelf registration
8:50am
S-3ASR
EX-5.1
shs43lrh ji5zs
8 Jul 20
Automatic shelf registration
8:50am
S-3ASR
pqup6ay75
8 Jul 20
Automatic shelf registration
8:50am
S-8
EX-5.1
vz2zd ftgu8
7 Jul 20
Registration of securities for employees
4:20pm
S-8
EX-10.1
7r7a6py6wjy4 nqs
7 Jul 20
Registration of securities for employees
4:20pm
8-K
EX-10.1
369an1s
15 Jun 20
Vaxart, Inc. Appoints New CEO to Accelerate Advancement of COVID-19 and Other Programs
5:25pm
8-K
EX-4.1
y6u8 4al9vjczxuk
2 Mar 20
Vaxart Announces $10.0 Million Registered Direct Offering Priced At-the-Market
2:48pm
8-K
EX-10.1
2g55jpba yprmb9
2 Mar 20
Vaxart Announces $10.0 Million Registered Direct Offering Priced At-the-Market
2:48pm
8-K
EX-99.1
tdc89wh7ch8gwx m8fhg
2 Mar 20
Vaxart Announces $10.0 Million Registered Direct Offering Priced At-the-Market
2:48pm